Tower Research Capital LLC (TRC) - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 443 filers reported holding CRISPR THERAPEUTICS AG in Q4 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$193,861
-74.8%
4,271
-68.8%
0.01%
-76.9%
Q2 2023$769,736
+91317.6%
13,711
-26.3%
0.03%
-3.7%
Q1 2023$842
+510.1%
18,615
+448.1%
0.03%
+350.0%
Q4 2022$138
-100.0%
3,396
-87.4%
0.01%
-79.3%
Q3 2022$1,763,000
+62.5%
26,990
+51.1%
0.03%
+20.8%
Q2 2022$1,085,000
+162.7%
17,862
+171.9%
0.02%
+500.0%
Q1 2022$413,000
+76.5%
6,570
+113.0%
0.00%0.0%
Q4 2021$234,000
-28.2%
3,085
+5.9%
0.00%
-50.0%
Q3 2021$326,000
-83.3%
2,912
-75.9%
0.01%
-84.3%
Q2 2021$1,953,000
-64.8%
12,061
-73.5%
0.05%
-45.2%
Q1 2021$5,552,000
+997.2%
45,570
+1278.8%
0.09%
+520.0%
Q4 2020$506,000
+932.7%
3,305
+462.1%
0.02%
+1400.0%
Q3 2020$49,000
+172.2%
588
+142.0%
0.00%0.0%
Q2 2020$18,000
-71.0%
243
-76.1%
0.00%
-80.0%
Q4 2019$62,000
+3000.0%
1,016
+2061.7%
0.01%
Q3 2019$2,000
-85.7%
47
-83.7%
0.00%
-100.0%
Q2 2019$14,000
-65.9%
288
-74.9%
0.00%
-50.0%
Q1 2019$41,000
-95.6%
1,148
-96.5%
0.00%
-97.0%
Q4 2018$929,000
+1329.2%
32,502
+2103.5%
0.07%
+1240.0%
Q3 2018$65,000
+71.1%
1,475
+125.9%
0.01%
+150.0%
Q2 2018$38,000
-67.2%
653
-74.2%
0.00%
-80.0%
Q1 2018$116,000
+364.0%
2,532
+82.6%
0.01%
+400.0%
Q3 2017$25,000
+150.0%
1,387
+189.6%
0.00%
+100.0%
Q4 2016$10,0004790.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q4 2021
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$27,989,04633.20%
Gilfoyle Management LLC 100$4,84215.90%
NEA Management Company, LLC 1,587,854$89,142,1246.80%
ARK Investment Management 7,338,447$411,980,3942.73%
Nikko Asset Management Americas, Inc. 3,533,357$198,327,3282.09%
Del-Sette Capital Management, LLC 33,661$1,889,7291.79%
Ikarian Capital, LLC 200,000$11,228,0001.79%
Ikarian Capital, LLC 200,000$11,228,0001.79%
Merlin Capital, Inc 8,802$494,1441.67%
Green Alpha Advisors, LLC 34,373$1,929,7001.27%
View complete list of CRISPR THERAPEUTICS AG shareholders